drugset / Trial / NCT03205462
An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers
Phase 1
Completed
25 enrolled
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Center of Pharmaceutical Analytics LLC · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
The current Phase I clinical trial has been developed to assess the safety and tolerability of the Fluorothyazinone drug used as a single-dose administration and a treatment course in healthy volunteers. This dose-escalation trial will be conducted with sequential enrollment of volunteers.
Timeline
- Start
- 2017-08-10
- Primary completion
- 2017-12-08
- Completion
- 2017-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluorothyazinone | Unknown | 300 mg | Oral |
| Subject | Fluorothyazinone | Unknown | 600 mg | Oral |
Indications
No indication recorded.